Poul Sorensen
Direttore Tecnico/Scientifico/R&S presso Novelix Pharmaceuticals, Inc.
Profilo
Poul Sorensen is Chief Science Consultant of Novelix Pharmaceuticals, Inc. He is Director of the Tumor Genetics Laboratory and a Professor of Pathology at the University of British Columbia, and a Senior Scientist at the British Columbia Cancer Research Centre in Vancouver, Canada.
Dr. Sorensen has over 15 years experience in tumor biology and cancer drug target identification.
Posizioni attive di Poul Sorensen
| Società | Posizione | Inizio |
|---|---|---|
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1995 |
| University of British Columbia | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
- Borsa valori
- Insiders
- Poul Sorensen